Stay updated on Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.

Latest updates to the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed. This update concerns metadata only and does not alter the study details or user-facing content on the page.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no substantive changes to the study details or core content observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check35 days agoChange DetectedAdded Revision: v3.4.1; removed the funding-status notice and the prior Revision: v3.4.0 notice.SummaryDifference0.1%

- Check42 days agoChange DetectedA site-wide notice about a lapse in government funding was added at the top of the page. The notice states that the NIH Clinical Center is open and directs users to cc.nih.gov and opm.gov for status updates.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded a glossary toggle (Show glossary) and updated metadata to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed the older lowercase version of the QC note and the previous Revision: v3.3.4 label.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 in the page footer.SummaryDifference0.0%

Stay in the know with updates to Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ligelizumab in Chronic Urticaria: Efficacy & Safety Clinical Trial page.